Home-based video visits for Type 1 Diabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of California-Davis, Sacramento, CAType 1 DiabetesHome-based video visits - Behavioral
Eligibility
5 - 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test if extra video visits and remote monitoring can help kids with uncontrolled type 1 diabetes better manage their blood sugar levels over 6 months, and compare how well these two interventions work compared to usual care.

Eligible Conditions
  • Type 1 Diabetes

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: through study completion, an average of 1 year

Month 6
Patient-reported outcomes
Month 6
Glycemic control
Month 6
Healthcare utilization
Week 52
Patient experience survey
Months 7-12 after enrollment
Glycemic Control
Year 1
Use of diabetes technology

Trial Safety

Safety Progress

1 of 3

Trial Design

4 Treatment Groups

Standard of Care
1 of 4
Home-based video visits
1 of 4
Supplemental video visits
1 of 4
Supplemental remote monitoring
1 of 4

Active Control

Experimental Treatment

100 Total Participants · 4 Treatment Groups

Primary Treatment: Home-based video visits · No Placebo Group · N/A

Home-based video visitsExperimental Group · 2 Interventions: Home-based video visits, Standard of Care · Intervention Types: Behavioral, Behavioral
Supplemental video visitsExperimental Group · 2 Interventions: Standard of Care, Supplemental video visits · Intervention Types: Behavioral, Behavioral
Supplemental remote monitoringExperimental Group · 2 Interventions: Standard of Care, Supplemental remote monitoring · Intervention Types: Behavioral, Behavioral
Standard of Care
Behavioral
ActiveComparator Group · 1 Intervention: Standard of Care · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard of Care
2017
Completed Phase 4
~4630

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 1 year

Who is running the clinical trial?

University of California, DavisLead Sponsor
855 Previous Clinical Trials
5,025,223 Total Patients Enrolled

Eligibility Criteria

Age 5 - 18 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You should be able to connect your home blood glucose monitor or CGM device, and insulin pump (if you use one) to an internet-enabled device using Bluetooth or cable.
You have a device with internet access, a camera, and a microphone.

Frequently Asked Questions

Are there any restrictions to enrolling in this medical survey?

"This clinical trial is searching for one hundred children aged between five and eighteen years old, who are living with diabetes or autoimmune disorders. Furthermore, they must have inadequate glycemic control (HbA1c > 8%/64 mmol/mol), a minimum of twelve months since the date of type 1 diabetes diagnosis, access to an internet-enabled device that supports audio and video technology, as well as Bluetooth or physical cable capabilities for connecting their home glucose monitor and insulin pump - if applicable." - Anonymous Online Contributor

Unverified Answer

How many individuals is this clinical trial enrolling?

"Affirmative. The clinicaltrial.gov database reveals that this trial is presently enrolling candidates, having been posted on September 15th 2022 and last updated a fortnight later. An approximate hundred subjects are being sought at one specified site." - Anonymous Online Contributor

Unverified Answer

Is participation in this scientific research limited to those aged 75 or below?

"This study has outlined an age range for inclusion of 5 to 18 years old. As such, there are 216 trials that cater exclusively to minors and 920 studies suitable for patients over the retirement age." - Anonymous Online Contributor

Unverified Answer

Is there still availability for participants in this medical demonstration?

"The data posted on clinicaltrials.gov affirms that this medical study, which was originally advertised on September 15th 2022, is actively seeking participants. The trial details were last updated on the 29th of the same month." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.